TrialThe Korean journal of internal medicine2010

Application of cystatin C reduction ratio to high-flux hemodialysis as an alternative indicator of the clearance of middle molecules.

Joon-Sung Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.